Skip to Main Content

Paper Details

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).
Journal of Clinical Oncology
29
2019
Author NameAffiliation
Charles LuThe University of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2